BCLSI
Bain Capital Life Sciences Investors’s Mersana Therapeutics MRSN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.56M | Hold |
8,663,673
| – | – | 0.32% | 19 |
|
|
2025
Q1 | $2.98M | Hold |
8,663,673
| – | – | 0.44% | 19 |
|
|
2024
Q4 | $12.4M | Hold |
8,663,673
| – | – | 1.46% | 14 |
|
|
2024
Q3 | $16.4M | Hold |
8,663,673
| – | – | 1.7% | 11 |
|
|
2024
Q2 | $17.4M | Hold |
8,663,673
| – | – | 1.91% | 11 |
|
|
2024
Q1 | $38.8M | Hold |
8,663,673
| – | – | 3.12% | 11 |
|
|
2023
Q4 | $20.1M | Hold |
8,663,673
| – | – | 1.93% | 13 |
|
|
2023
Q3 | $11M | Hold |
8,663,673
| – | – | 1.23% | 20 |
|
|
2023
Q2 | $28.5M | Hold |
8,663,673
| – | – | 2.94% | 13 |
|
|
2023
Q1 | $35.6M | Hold |
8,663,673
| – | – | 4.45% | 8 |
|
|
2022
Q4 | $50.8M | Hold |
8,663,673
| – | – | 5.67% | 5 |
|
|
2022
Q3 | $58.6M | Hold |
8,663,673
| – | – | 6.99% | 3 |
|
|
2022
Q2 | $40M | Buy |
8,663,673
+2,141,643
| +33% | +$9.89M | 4.69% | 8 |
|
|
2022
Q1 | $26M | Buy |
6,522,030
+1,136,363
| +21% | +$4.53M | 2.53% | 11 |
|
|
2021
Q4 | $33.5M | Buy |
5,385,667
+1,690,000
| +46% | +$10.5M | 2.66% | 13 |
|
|
2021
Q3 | $34.9M | Hold |
3,695,667
| – | – | 2.16% | 14 |
|
|
2021
Q2 | $50.2M | Hold |
3,695,667
| – | – | 3.29% | 9 |
|
|
2021
Q1 | $59.8M | Buy |
3,695,667
+250,000
| +7% | +$4.05M | 3.39% | 9 |
|
|
2020
Q4 | $91.7M | Hold |
3,445,667
| – | – | 5.76% | 4 |
|
|
2020
Q3 | $64.2M | Hold |
3,445,667
| – | – | 5.98% | 5 |
|
|
2020
Q2 | $80.6M | Buy |
+3,445,667
| New | +$80.6M | 8.44% | 5 |
|